Articles |
From the TNOPrevention and Health, Gaubius Laboratory (W.L.H., B.J.M. van V., F. van der S.-de B., L.C. van V., L.M.H), and the MGCDepartment of Human Genetics, Leiden University (M.H.H.), Leiden, The Netherlands.
Correspondence to Dr L.M. Havekes, TNOPrevention and Health, Gaubius Laboratory, Zernikedreef 9, 2333 CK Leiden, PO Box 2215, 2301 CE Leiden, The Netherlands. E-mail lm.havekes{at}pg.tno.nl.
Abstract Apolipoprotein (apo) Edeficient mice display marked accumulation in the plasma of VLDL deficient in both apoE and apoB100 but containing apoB48, apoA-I, apoCs, and apoA-IV. Since apoE-deficient mice develop severe atherosclerotic lesions with lipid-laden macrophages, we reasoned that the uptake of lipoproteins by intimal macrophages can take place in the absence of both apoE and apoB100. To get more insight into the mechanism of foam cell formation in apoE-deficient mice, we measured the interaction of VLDL from apoE-deficient mice (apoEnull VLDL) with the murine macrophage cell line J774. Scatchard analysis revealed that apoEnull VLDL is bound to J774 cells with a Kd value comparable to that of control VLDL (8.1 versus 4.7 µg/mL) and with a Bmax value about half that of control VLDL (40 versus 70 ng/mg cell protein, respectively). ApoEnull VLDL is also taken up and degraded by J774 macrophages via a high-affinity process less efficiently than control mouse VLDL (6-fold and 50-fold less efficiently, respectively). In line with this observation, incubation of J774 cells with 50 µg/mL apoEnull VLDL for 24 hours resulted in an increase in intracellular cholesteryl ester (CE) content, although 5-fold less pronounced than after incubation with 50 µg/mL control mouse VLDL. Under the conditions applied, simultaneous addition of 5 µg/mL lipoprotein lipase (LPL) stimulated the cellular uptake and degradation of apoEnull VLDL about 10-fold and resulted in a 5-fold stimulation of the intracellular CE accumulation, from 9±2 to 46±5 µg CE per milligram cell protein. In contrast to control mouse VLDL, apoEnull VLDL could not compete with 125I-labeled LDL for binding to the LDL receptor of J774 cells. Furthermore, neither LDL nor acetylated LDL could compete with 125I-labeled apoEnull VLDL for binding to these cells, whereas control mouse VLDL, VLDL from a hypertriglyceridemic patient, and apoEnull VLDL itself were efficient competitors. Thus, VLDL from apoE-deficient mice is taken up by J774 macrophages through recognition by a distinct receptor, which could be the triglyceride-rich lipoprotein receptor. We conclude that in apoE-deficient mice, foam cell formation occurs via a receptor-mediated uptake of apoEnull VLDL, which can be stimulated by the presence of LPL.
Key Words: apoE-deficient mice macrophages foam cells receptor-mediated uptake lipoprotein lipase
This article has been cited by other articles:
![]() |
M.-D. Wang, R. S. Kiss, V. Franklin, H. M. McBride, S. C. Whitman, and Y. L. Marcel Different cellular traffic of LDL-cholesterol and acetylated LDL-cholesterol leads to distinct reverse cholesterol transport pathways J. Lipid Res., March 1, 2007; 48(3): 633 - 645. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhao, M. C. de Beer, L. Cai, R. Asmis, F. C. de Beer, W. J.S. de Villiers, and D. R. van der Westhuyzen Low-Density Lipoprotein From Apolipoprotein E-Deficient Mice Induces Macrophage Lipid Accumulation in a CD36 and Scavenger Receptor Class A-Dependent Manner Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 168 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Brown, K. Yui, J. D. Smith, R. C. LeBoeuf, W. Weng, P. K. Umeda, R. Li, R. Song, S. H. Gianturco, and W. A. Bradley The murine macrophage apoB-48 receptor gene (Apob-48r): homology to the human receptor J. Lipid Res., August 1, 2002; 43(8): 1181 - 1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Marathe, Y. Choi, A. R. Leventhal, and I. Tabas Sphingomyelinase Converts Lipoproteins From Apolipoprotein E Knockout Mice Into Potent Inducers of Macrophage Foam Cell Formation Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20(12): 2607 - 2613. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Medh, G. L. Fry, S. L. Bowen, S. Ruben, H. Wong, and D. A. Chappell Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism J. Lipid Res., November 1, 2000; 41(11): 1858 - 1871. [Abstract] [Full Text] |
||||
![]() |
S. Marathe, G. Kuriakose, K. J. Williams, and I. Tabas Sphingomyelinase, an Enzyme Implicated in Atherogenesis, Is Present in Atherosclerotic Lesions and Binds to Specific Components of the Subendothelial Extracellular Matrix Arterioscler. Thromb. Vasc. Biol., November 1, 1999; 19(11): 2648 - 2658. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Cohn, C. Marcoux, and J. Davignon Detection, Quantification, and Characterization of Potentially Atherogenic Triglyceride-Rich Remnant Lipoproteins Arterioscler. Thromb. Vasc. Biol., October 1, 1999; 19(10): 2474 - 2486. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Fujioka, A. D. Cooper, and L. G. Fong Multiple processes are involved in the uptake of chylomicron remnants by mouse peritoneal macrophages J. Lipid Res., December 1, 1998; 39(12): 2339 - 2349. [Abstract] [Full Text] |
||||
![]() |
C. F. Semenkovich, T. Coleman, and A. Daugherty Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice J. Lipid Res., June 1, 1998; 39(6): 1141 - 1151. [Abstract] [Full Text] |
||||
![]() |
W. J. S. de Villiers, J. D. Smith, M. Miyata, H. M. Dansky, E. Darley, and S. Gordon Macrophage Phenotype in Mice Deficient in Both Macrophage-Colony–Stimulating Factor (Op) and Apolipoprotein E Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 631 - 640. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |